Skip to main content
. 2022 Jun 4;11(11):1843. doi: 10.3390/cells11111843

Figure 1.

Figure 1

Overview of hematopoietic stem cell (HSC)-targeted gene therapy in sickle cell disease (SCD). A schema of discussion points in autologous HSC therapy with gene addition/editing in SCD.